Part of this may be due to the fact that there may be genetic alterations in other genes not yet associated with hereditary breast cancer or the presence of genetic alterations in other high/moderate risk genes for which the patients were not tested (such as TP53 and PALB2). This evidence concerns the gene PALB2 and breast carcinoma.